Serine leucocyte proteinase inhibitor-treated monocyte inhibits human CD4(+) lymphocyte proliferation

Serine leucocyte proteinase inhibitor (SLPI) is the main serine proteinase inhibitor produced by epithelial cells and has been shown to be a pleiotropic molecule with anti-inflammatory and microbicidal activities. However, the role of SLPI on the adaptive immune response is not well established. The...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Guerrieri, Diego, Tateosian, Nancy L, Maffía, Paulo C, Reiteri, Romina M, Amiano, Nicolás O, Costa, María J, Villalonga, Ximena, Sanchez, Mercedes L, Estein, Silvia M, Garcia, Verónica E, Sallenave, Jean-Michel, Chuluyan, Héctor E
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Blackwell Science Inc 2011
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3143355/
https://ncbi.nlm.nih.gov/pubmed/21574992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2567.2011.03451.x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller